$3.92 -0.17 (-4.03%)

Clearside Biomedical, Inc. Common Stock (CLSD)

Clearside Biomedical, Inc. is a biopharmaceutical company focused on developing therapies for the treatment of ocular diseases. The company specializes in entregaric drugs with its proprietary Suprachoroidal Space (SCS) delivery platform, which enables targeted delivery of medications to the back of the eye. Clearside's pipeline includes treatments aimed at retinal diseases, uveitis, and other vision-threatening conditions.

🚫 Clearside Biomedical, Inc. Common Stock does not pay dividends

Company News

12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga • Benzinga Staff Writer • September 26, 2025

Multiple healthcare stocks experienced significant pre-market price movements, with some companies seeing notable gains while others faced declines.

Comprehensive Age-related Macular Degeneration Market Analysis: Trends and Developments Across All Types
GlobeNewswire Inc. • Delveinsight • June 16, 2025

The age-related macular degeneration (AMD) market is expected to grow due to the launch of new therapies and increased healthcare spending. Dry AMD and wet AMD are the two main types, with new treatments in development for both.

Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Misses Revenue Estimates
Zacks Investment Research • Zacks Equity Research • May 9, 2024

Clearside Biomedical (CLSD) delivered earnings and revenue surprises of -21.43% and 76.43%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Retail Traders Are Watching These Penny Stocks in March 2022
PennyStocks • J. Phillip • March 15, 2022

Retail traders are watching these penny stocks, here's why The post Retail Traders Are Watching These Penny Stocks in March 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Wall Street Breakfast: The Week Ahead
Seeking Alpha • Wall Street Breakfast • October 10, 2021

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.